摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

5-methyl-2',5'-dichloro-2',5'-dideoxyuridine | 85254-35-9

中文名称
——
中文别名
——
英文名称
5-methyl-2',5'-dichloro-2',5'-dideoxyuridine
英文别名
2',5'-Dichloro-5'-deoxythymidine;1-[(2R,3R,4R,5S)-3-chloro-5-(chloromethyl)-4-hydroxyoxolan-2-yl]-5-methylpyrimidine-2,4-dione
5-methyl-2',5'-dichloro-2',5'-dideoxyuridine化学式
CAS
85254-35-9
化学式
C10H12Cl2N2O4
mdl
——
分子量
295.122
InChiKey
CSJFOEWFKYZXSU-JXOAFFINSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 密度:
    1.57±0.1 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.1
  • 重原子数:
    18
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.6
  • 拓扑面积:
    78.9
  • 氢给体数:
    2
  • 氢受体数:
    4

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    5-methyl-2',5'-dichloro-2',5'-dideoxyuridinesodium hydroxide 作用下, 以 甲醇 为溶剂, 反应 3.0h, 以93%的产率得到5-methyl-2,5'-anhydro-1-β-D-arabinofuranosyluracil
    参考文献:
    名称:
    Nucleosides. II. Direct synthesis of 5-substituted 2',5'-anhydro-1-.BETA.-D-arabinofuranosyluracils from uridine derivatives.
    摘要:
    在回流条件下,5-取代的 2',5'-二氯-2',5'-二脱氧尿苷(1a-d)与甲醇氢氧化钠反应,可以得到相应的 5-取代的 2',5'-脱水-1-β-D-阿拉伯呋喃糖基尿嘧啶(3a-d),产率很高。另一方面,5-取代的尿苷 (5a-d) 与 Vilsmeier-Haack 试剂(POCl3/DMF)反应,然后在回流条件下用甲醇氢氧化钠处理,可直接生成相应的无水尿苷 (3a-d),收率很高。
    DOI:
    10.1248/cpb.33.4212
  • 作为产物:
    参考文献:
    名称:
    A Direct Synthesis of 2′,5′-Dihalo-2′,5′-dideoxyuridines from Uridine Derivatives
    摘要:
    DOI:
    10.1055/s-1983-30245
点击查看最新优质反应信息

文献信息

  • Simple method for the synthesis of 5-substituted 2′,5′-anhydro-2′,5′-dideoxy-1-β-<scp>D</scp>-arabinofuranosyluracils
    作者:Kosaku Hirota、Yukio Kitade、Tetsuo Tomishi、Yoshifumi Maki
    DOI:10.1039/c39840000108
    日期:——
    Reaction of 5-substituted 2′,5′-dichloro-2′,5′-dideoxyuridines (1) with methanolic sodium hydroxide under reflux afforded the corresponding 5-substituted 2′,5-anhydro-2′,5′-dideoxy-1-β-D-arabinofuranosyluracils (2) in high yields.
    5-取代的2',5'-二氯-2',5'-二脱氧尿苷(1)与甲醇氢氧化钠在回流下反应,得到相应的5-取代的2',5'-脱水-2',5'-二脱氧-1-β- D-阿拉伯呋喃糖基尿嘧啶(2)高产。
  • A Direct Synthesis of 2′,5′-Dihalo-2′,5′-dideoxyuridines from Uridine Derivatives
    作者:Kosaku Hirota、Yukio Kitade、Fumiaki Iwami、Shigeo Senda、Yoshifumi Maki
    DOI:10.1055/s-1983-30245
    日期:——
  • Nucleosides. II. Direct synthesis of 5-substituted 2',5'-anhydro-1-.BETA.-D-arabinofuranosyluracils from uridine derivatives.
    作者:KOSAKU HIROTA、YUKIO KITADE、TETSUO TOMISHI、YOSHIFUMI MAKI
    DOI:10.1248/cpb.33.4212
    日期:——
    Reaction of 5-substituted 2', 5'-dichloro-2', 5'-dideoxyuridines (1a-d) with methanolic sodium hydroxide under reflux afforded the corresponding 5-substituted 2', 5'-anhydro-1-β-D-arabino-furanosyluracils (3a-d) in high yield. On the other hand, reaction of 5-substituted uridines (5a-d) with the Vilsmeier-Haack reagent (POCl3/DMF) followed by treatment with methanolic sodium hydroxide under reflux led directly to the formation of the corresponding anhydrouridines (3a-d) in good yield.
    在回流条件下,5-取代的 2',5'-二氯-2',5'-二脱氧尿苷(1a-d)与甲醇氢氧化钠反应,可以得到相应的 5-取代的 2',5'-脱水-1-β-D-阿拉伯呋喃糖基尿嘧啶(3a-d),产率很高。另一方面,5-取代的尿苷 (5a-d) 与 Vilsmeier-Haack 试剂(POCl3/DMF)反应,然后在回流条件下用甲醇氢氧化钠处理,可直接生成相应的无水尿苷 (3a-d),收率很高。
查看更多

同类化合物

鲁西他滨 化合物 T14195 [1,1'-联苯基]-2,3,3',4,4',5'-六醇 [(2R,3R,5S)-3-(氨基甲基)-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]N-[[(2R,3S,5R)-3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]氨基甲酸酯 9-(2-S-苯甲基-5-脱氧-2-硫代五呋喃糖基)-9H-嘌呤-6-胺 5-脱氧胸苷 5-脱氧-5-[(碘乙酰基)氨基]-胸腺嘧啶脱氧核苷 5-碘-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-5-脱氧胸腺嘧啶脱氧核苷 5-氨基-2,5-二脱氧腺苷酸 5-叠氮基-5-脱氧胸腺嘧啶脱氧核苷 5-三氟乙酰氨基-5-脱氧胸腺嘧啶脱氧核苷 5'-脱氧-5'氟胸苷 5'-脱氧-5'-{[4-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-{[3-(甲硫基)苯胺基羰基]氨基}胸苷 5'-脱氧-5'-[4-苯基-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(吡啶-3-基)-(1,2,3)三唑-1-基]胸苷 5'-脱氧-5'-[4-(4-氟苯基)-(1,2,3)三唑-1-基]胸苷 5'-硫代-胸苷3',5'-二乙酸酯 5'-溴乙酰氨基-5'-脱氧胸苷 5'-氨基-5-碘-2',5'-二脱氧尿苷 2-氯-N-[[3-羟基-5-(5-甲基-2,4-二氧代嘧啶-1-基)四氢呋喃-2-基]甲基]乙酰胺 2,5-二脱氧腺苷 2',5'-二脱氧尿苷 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]嘧啶-2,4-二酮 1-[(2R,4S,5R)-4-羟基-5-(异氰基甲基)四氢呋喃-2-基]-5-甲基嘧啶-2,4-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)嘧啶-2,4(1H,3H)-二酮 1-(2,5-二脱氧-2-氟-β-D-呋喃阿拉伯糖基)-5-碘嘧啶-2,4(1H,3H)-二酮 1-citosin-1-yl-1,2,5-trideoxy-α-L-threo-pentofuranos-4-yloxymethylphosphonic acid 9-[2,5-dideoxy-2-fluoro-5-[N-(N-2-hydroxybenzoyl)sulfamoyl]amino-β-D-ribofuranosyl]adenine triethylammonium salt 5'-amino-2',5'-dideoxy-2'-fuorouridine 1-(5'-deoxythymidin-5'-yl)-4-[methyloxycarbonyl-(2'-deoxy-2',2'-difluorocytidin-4N-yl)]-1H-1,2,3-triazole 2',5'-dideoxy-2'-(3,5-dimethoxybenzamido)-5'-(cyclohexylacetamido)adenosine 2',5'-dideoxy-2'-(3'',5''-dimethoxybenzamido)-5'-(diphenylacetamido)adenosine 2',5'-dideoxy-5'-(hydroxyethylthio)adenosine 1-(5-azido-2,5-dideoxy-2-fluoro-β-D-arabinofuranosyl)-5-ethyluracil 1-(5'-deoxythymidin-5'-yl)-4-[methyl-(2'-deoxy-2',2'-difluorocytidin-4N-yl)]-1H-1,2,3-triazole 4′-C-azidomethyl-2′-deoxy-2′-fluorouridine 2',5'-dideoxy-6-thioguanosine thymidylyl (3'-5') 5'-seleno-5'-deoxythymidine 3'-O-(t-butyldimethylsilyl)-4'-α-methylthymidine (E)- and (Z)-5-(2-bromovinyl)-1-(5-chloro-2,5-dideoxy-β-D-erythro-pentofuranosyl)-5-methyl-4-(1,2,4-triazol-1-yl)pyrimidin-2(1H)-one N-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranos-5-yl>succinamic acid N-butyl-N'-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranose-5-yl>maleamide N-<1,2,5-trideoxy-1β-(5-fluoro-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1-yl)-D-ribofuranos-5-yl>maleamic acid 4'-chloromethyl-2'-deoxy-2',2'-difluorocytidine 4'-chloromethyl-2'-deoxy-2'-fluoro-3'-O-(L-valinyl)cytidine dihydrochloride 5'-deoxy-5'-{4-[2-(3-oxo-3H-benzo[f]chromen-1-yl)acetamidomethyl]-1H-1,2,3-triazol-1-yl}thymidine N6-benzoyl-3'-O-t-butyldimethylsilyl-5'-sulfamoylazido-2',5'-dideoxyadenosine N-{9-[(2R,4S,5R)-5-(Acetylamino-methyl)-4-hydroxy-tetrahydro-furan-2-yl]-9H-purin-6-yl}-benzamide